EFFECT OF INTERFERON-GAMMA ON MYELIN BASIC PROTEIN-SPECIFIC T-CELL LINE PROLIFERATION IN RESPONSE TO ANTIGEN-PULSED ACCESSORY CELLS

被引:11
作者
DUONG, TT [1 ]
FINKELMAN, FD [1 ]
STREJAN, GH [1 ]
机构
[1] UNIFORMED SERV UNIV HLTH SCI,DEPT MED,BETHESDA,MD 20814
关键词
D O I
10.1016/0008-8749(92)90334-L
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have shown previously that treatment of SJL/J mice with anti-interferon-γ monoclonal antibody (mAb) exacerbated experimental allergic encephalomyelitis (EAE) only if administered at the time of encephalitogenic challenge. Here we investigate the role of interferon-γ (IFN-γ) and anti-IFN-γ mAb in the early events of T cell activation in vitro. Pretreatment of murine peritoneal exudate cells (PEC) with IFN-γ led to a significant increase in their ability to activate myelin basic protein (MBP)-specific, short-term T cell lines. When exogenous IFN-γ was added to cocultures of T cells and MBP-pulsed PEC, the antigen-specific T cell proliferation was considerably reduced. Anti-IFN-γ mAb added to these cultures neutralized the inhibitory effect of the exogenous IFN-γ on T cell proliferation but had no visible effect on class II MHC expression by the antigen-pulsed PEC present in the same cultures. A reduction in T cell proliferation was also observed when the T cells were treated with IFN-γ prior to coculture with the MBP-pulsed PEC. These results demonstrate that, on one hand, IFN-γ enhances the ability of PEC to induce antigen-specific T cell proliferation but, on the other hand, acts on the T cells themselves by inhibiting their proliferation in response to the antigen-pulsed PEC. This may explain why treatment with anti-IFN-γ antibody in vivo induces EAE exacerbation. © 1992.
引用
收藏
页码:311 / 323
页数:13
相关论文
共 35 条
[1]  
ABREU SL, 1992, IMMUNOL COMMUN, V11, P1
[2]   SUPPRESSION OF LYMPHOCYTE-PROLIFERATION THROUGH THE NITRIC-OXIDE SYNTHESIZING PATHWAY [J].
ALBINA, JE ;
HENRY, WL .
JOURNAL OF SURGICAL RESEARCH, 1991, 50 (04) :403-409
[3]  
ALBINA JE, 1991, J IMMUNOL, V147, P144
[4]  
ARENZANASEISDEDOS F, 1985, J IMMUNOL, V134, P2444
[5]  
BECKMANN MP, 1990, J IMMUNOL, V144, P4212
[6]   FUNCTIONAL-SIGNIFICANCE OF THE REGULATION OF MACROPHAGE-IA EXPRESSION [J].
BELLER, DI .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (02) :138-143
[7]  
BILLIAU A, 1988, J IMMUNOL, V140, P1506
[8]   INTERFERON-GAMMA - MECHANISM OF ACTION AND THERAPEUTIC POTENTIAL [J].
BILLIAU, A ;
DIJKMANS, R .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1433-1439
[9]  
BROWN A, 1982, LAB INVEST, V46, P171
[10]  
CAO H, 1989, J IMMUNOL, V143, P3524